HONG KONG, Sept. 6, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will participate in the following investor conferences:
For further details, please contact your respective institutional sales representatives.
About China Cord Blood CorporationChina Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses. Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com. For more information, please contact:China Cord Blood CorporationMs. Joeling LawTel: +852-3605-8180Email: firstname.lastname@example.org ICR, Inc.In New York: Ashley Ammon De Simone: +1-646-277-1227In Beijing: Wen Lei Zheng: +86-10-6583-7510
|SOURCE China Cord Blood Corporation|
Copyright©2010 PR Newswire.
All rights reserved